JENNIFER WATSON: Open Payments
NPI 1912575176 · PALESTINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,720 in 73 payments from 28 companies in 2025. Trend: 2023 $871 · 2024 $1,938 · 2025 $1,720
Food & beverage: $1,720
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $231 |
| ABBVIE INC. | 10 | $228 |
| Regeneron Healthcare Solutions, Inc. | 10 | $184 |
| Tempus AI, Inc | 5 | $157 |
| Myriad Genetic Laboratories, Inc. | 2 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Genmab U.S., Inc. | 2 | $55 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $54 |
Products named: EPKINLY, XT CDX, LIBTAYO, IMFINZI, MYRISK, KISQALI, IMJUDO, Nubeqa.
Industry payments across TX — which companies pay providers there.
